• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌萎缩侧索硬化症的骨骼肌。

Skeletal muscle in amyotrophic lateral sclerosis.

机构信息

Barrow Neurological Institute, Phoenix, AZ, USA.

College of Medicine, University of Arizona, Phoenix, AZ, USA.

出版信息

Brain. 2023 Nov 2;146(11):4425-4436. doi: 10.1093/brain/awad202.

DOI:10.1093/brain/awad202
PMID:37327376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10629757/
Abstract

Amyotrophic lateral sclerosis (ALS), the major adult-onset motor neuron disease, has been viewed almost exclusively as a disease of upper and lower motor neurons, with muscle changes interpreted as a consequence of the progressive loss of motor neurons and neuromuscular junctions. This has led to the prevailing view that the involvement of muscle in ALS is only secondary to motor neuron loss. Skeletal muscle and motor neurons reciprocally influence their respective development and constitute a single functional unit. In ALS, multiple studies indicate that skeletal muscle dysfunction might contribute to progressive muscle weakness, as well as to the final demise of neuromuscular junctions and motor neurons. Furthermore, skeletal muscle has been shown to participate in disease pathogenesis of several monogenic diseases closely related to ALS. Here, we move the narrative towards a better appreciation of muscle as a contributor of disease in ALS. We review the various potential roles of skeletal muscle cells in ALS, from passive bystanders to active players in ALS pathophysiology. We also compare ALS to other motor neuron diseases and draw perspectives for future research and treatment.

摘要

肌萎缩侧索硬化症(ALS)是一种主要的成年起病的运动神经元疾病,几乎完全被视为上运动神经元和下运动神经元疾病,肌肉变化被解释为运动神经元和神经肌肉接头进行性丧失的结果。这导致了目前的观点,即肌肉在 ALS 中的参与仅仅是运动神经元丧失的继发结果。骨骼肌和运动神经元相互影响各自的发育,并构成一个单一的功能单元。在 ALS 中,多项研究表明,骨骼肌功能障碍可能导致进行性肌肉无力,以及神经肌肉接头和运动神经元的最终死亡。此外,已经表明骨骼肌参与了与 ALS 密切相关的几种单基因疾病的发病机制。在这里,我们将叙述方式转向更好地理解肌肉在 ALS 中的作用。我们回顾了骨骼肌细胞在 ALS 中的各种潜在作用,从被动旁观者到 ALS 病理生理学中的主动参与者。我们还将 ALS 与其他运动神经元疾病进行了比较,并为未来的研究和治疗提供了观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/30c9121694de/awad202f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/f130625a9958/awad202f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/4c667d8c4c90/awad202f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/26e43da620aa/awad202f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/30c9121694de/awad202f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/f130625a9958/awad202f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/4c667d8c4c90/awad202f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/26e43da620aa/awad202f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/691e/10629757/30c9121694de/awad202f4.jpg

相似文献

1
Skeletal muscle in amyotrophic lateral sclerosis.肌萎缩侧索硬化症的骨骼肌。
Brain. 2023 Nov 2;146(11):4425-4436. doi: 10.1093/brain/awad202.
2
Neuromuscular Junction Dysfunction in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中的神经肌肉接头功能障碍。
Mol Neurobiol. 2022 Mar;59(3):1502-1527. doi: 10.1007/s12035-021-02658-6. Epub 2022 Jan 8.
3
Therapeutics Targeting Skeletal Muscle in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症中的骨骼肌治疗靶点。
Biomolecules. 2024 Jul 22;14(7):878. doi: 10.3390/biom14070878.
4
Neuromuscular Junction Dismantling in Amyotrophic Lateral Sclerosis.肌神经接点在肌萎缩性脊髓侧索硬化症中的解体。
Int J Mol Sci. 2017 Oct 3;18(10):2092. doi: 10.3390/ijms18102092.
5
Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).家族性肌萎缩侧索硬化症(ALS)大鼠模型骨骼肌中巨噬细胞介导的炎症和神经胶质反应。
Exp Neurol. 2016 Mar;277:275-282. doi: 10.1016/j.expneurol.2016.01.008. Epub 2016 Jan 13.
6
Muscle histone deacetylase 4 upregulation in amyotrophic lateral sclerosis: potential role in reinnervation ability and disease progression.肌肉组蛋白去乙酰化酶 4 在肌萎缩侧索硬化症中的上调:在重新支配能力和疾病进展中的潜在作用。
Brain. 2013 Aug;136(Pt 8):2359-68. doi: 10.1093/brain/awt164. Epub 2013 Jul 3.
7
Cholinergic modulation of motor neurons through the C-boutons are necessary for the locomotor compensation for severe motor neuron loss during amyotrophic lateral sclerosis disease progression.胆碱能通过 C-末梢对运动神经元的调制对于肌萎缩侧索硬化症疾病进展过程中严重运动神经元丧失的运动补偿是必要的。
Behav Brain Res. 2019 Sep 2;369:111914. doi: 10.1016/j.bbr.2019.111914. Epub 2019 Apr 22.
8
Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models.肌萎缩侧索硬化症中神经肌肉接头的破坏:转基因模型的见解
Curr Opin Pharmacol. 2009 Jun;9(3):341-6. doi: 10.1016/j.coph.2009.03.007. Epub 2009 Apr 20.
9
TDP-43 dysregulation and neuromuscular junction disruption in amyotrophic lateral sclerosis.TDP-43 失调与肌萎缩侧索硬化症中的运动神经元-肌肉接头破坏。
Transl Neurodegener. 2022 Dec 27;11(1):56. doi: 10.1186/s40035-022-00331-z.
10
Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis.肌神经接点去神经和末端许旺细胞丢失在 hTDP-43 过表达的肌萎缩性侧索硬化症小鼠模型中。
Neuropathol Appl Neurobiol. 2023 Aug;49(4):e12925. doi: 10.1111/nan.12925.

引用本文的文献

1
Genetic and Mechanistic Insights Inform Amyotrophic Lateral Sclerosis Treatment and Symptomatic Management: Current and Emerging Therapeutics and Clinical Trial Design Considerations.基因与机制见解为肌萎缩侧索硬化症的治疗及症状管理提供依据:当前与新兴疗法及临床试验设计考量
CNS Drugs. 2025 Sep 2. doi: 10.1007/s40263-025-01217-0.
2
The potential role of microRNA-mediated motor neuron-muscle pathologic interactions in amyotrophic lateral sclerosis.微小RNA介导的运动神经元与肌肉病理相互作用在肌萎缩侧索硬化症中的潜在作用
Mol Ther Nucleic Acids. 2025 Aug 23;36(3):102675. doi: 10.1016/j.omtn.2025.102675. eCollection 2025 Sep 9.
3

本文引用的文献

1
C-terminal frameshift variant of TDP-43 with pronounced aggregation-propensity causes rimmed vacuole myopathy but not ALS/FTD.TDP-43 的 C 末端移码变体具有明显的聚集倾向,导致镶边空泡肌病但不导致 ALS/FTD。
Acta Neuropathol. 2023 Jun;145(6):793-814. doi: 10.1007/s00401-023-02565-1. Epub 2023 Mar 31.
2
Sporadic Spinal-Onset Amyotrophic Lateral Sclerosis Associated with Myopathy in Three Unrelated Portuguese Patients.三名无血缘关系的葡萄牙患者中与肌病相关的散发性脊髓起病型肌萎缩侧索硬化症
Brain Sci. 2023 Jan 28;13(2):220. doi: 10.3390/brainsci13020220.
3
Defective excitation-contraction coupling and mitochondrial respiration precede mitochondrial Ca accumulation in spinobulbar muscular atrophy skeletal muscle.
A plasma proteomics-based candidate biomarker panel predictive of amyotrophic lateral sclerosis.
基于血浆蛋白质组学的预测肌萎缩侧索硬化症的候选生物标志物组。
Nat Med. 2025 Aug 19. doi: 10.1038/s41591-025-03890-6.
4
Glycerophospholipids in ALS: insights into disease mechanisms and clinical implication.肌萎缩侧索硬化症中的甘油磷脂:对疾病机制和临床意义的见解
Mol Neurodegener. 2025 Jul 26;20(1):85. doi: 10.1186/s13024-025-00876-3.
5
Kv3 channel agonist ameliorates the phenotype of a mouse model of amyotrophic lateral sclerosis.Kv3通道激动剂改善肌萎缩侧索硬化症小鼠模型的表型。
Acta Neuropathol Commun. 2025 Jul 14;13(1):153. doi: 10.1186/s40478-025-02067-z.
6
Deciphering hypothalamic pathology in ALS: insights into non-motor symptoms and disease progression.解读肌萎缩侧索硬化症中的下丘脑病理学:对非运动症状和疾病进展的见解。
EBioMedicine. 2025 Jul 11;118:105845. doi: 10.1016/j.ebiom.2025.105845.
7
Increased [F]DPA-714 Uptake in the Skeletal Muscle of SOD1 Mice: A New Potential of Translocator Protein 18 kDa Imaging in Amyotrophic Lateral Sclerosis.超氧化物歧化酶1型小鼠骨骼肌中[F]DPA - 714摄取增加:18 kDa转位蛋白成像在肌萎缩侧索硬化症中的新潜力
Biomolecules. 2025 May 31;15(6):799. doi: 10.3390/biom15060799.
8
Quantification of Skeletal Muscle at the First Lumbar Level for Prognosis in Amyotrophic Lateral Sclerosis.第一腰椎水平骨骼肌定量对肌萎缩侧索硬化症预后的评估
J Cachexia Sarcopenia Muscle. 2025 Jun;16(3):e13827. doi: 10.1002/jcsm.13827.
9
Different patterns of fasciculation in spinal and bulbar muscular atrophy and amyotrophic lateral sclerosis: a muscle ultrasonographic study.脊髓延髓肌肉萎缩症和肌萎缩侧索硬化症中不同类型的肌束震颤:一项肌肉超声研究
BMJ Neurol Open. 2025 Apr 24;7(1):e001065. doi: 10.1136/bmjno-2025-001065. eCollection 2025.
10
Global research trends in biomarkers, therapeutic targets, and drugs for amyotrophic lateral sclerosis: a bibliometric and visualization analysis.肌萎缩侧索硬化症生物标志物、治疗靶点和药物的全球研究趋势:文献计量学与可视化分析
Front Pharmacol. 2025 Apr 7;16:1588968. doi: 10.3389/fphar.2025.1588968. eCollection 2025.
脊髓性肌萎缩症骨骼肌中线粒体钙积累之前存在兴奋-收缩偶联和线粒体呼吸缺陷。
Nat Commun. 2023 Feb 6;14(1):602. doi: 10.1038/s41467-023-36185-w.
4
FUS Mutation Causes Disordered Lipid Metabolism in Skeletal Muscle Associated with ALS.FUS 突变导致 ALS 相关骨骼肌中脂质代谢紊乱。
Mol Neurobiol. 2022 Dec;59(12):7265-7277. doi: 10.1007/s12035-022-03048-2. Epub 2022 Sep 28.
5
Adult-onset dominant muscular dystrophy in Greek families caused by Annexin A11.希腊家族性成年型显性肌营养不良症与膜联蛋白 A11 相关
Ann Clin Transl Neurol. 2022 Oct;9(10):1660-1667. doi: 10.1002/acn3.51665. Epub 2022 Sep 22.
6
ALS mutations in both human skeletal muscle and motoneurons differentially affects neuromuscular junction integrity and function.在人类骨骼肌和运动神经元中,肌萎缩侧索硬化症的突变会对神经肌肉接头的完整性和功能产生不同的影响。
Biomaterials. 2022 Oct;289:121752. doi: 10.1016/j.biomaterials.2022.121752. Epub 2022 Aug 19.
7
Clinical phenotype of familial amyotrophic lateral sclerosis with gene mutation mimicking proximal myopathy: A case report and literature review.家族性肌萎缩侧索硬化伴基因突变模拟近端肌病的临床表型:病例报告及文献复习。
Clin Neuropathol. 2022 Sep-Oct;41(5):219-225. doi: 10.5414/NP301459.
8
Functional adaptation of glial cells at neuromuscular junctions in response to injury.神经肌肉接头处神经胶质细胞对损伤的功能适应性反应。
Glia. 2022 Sep;70(9):1605-1629. doi: 10.1002/glia.24184. Epub 2022 Apr 27.
9
Impaired signaling for neuromuscular synaptic maintenance is a feature of Motor Neuron Disease.神经肌肉突触维持的信号转导受损是运动神经元疾病的特征。
Acta Neuropathol Commun. 2022 Apr 25;10(1):61. doi: 10.1186/s40478-022-01360-5.
10
Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.对肌萎缩侧索硬化症复杂遗传学和病理生理学的新见解。
Lancet Neurol. 2022 May;21(5):465-479. doi: 10.1016/S1474-4422(21)00414-2. Epub 2022 Mar 22.